Literature DB >> 7759528

Members of the Sp transcription factor family control transcription from the uteroglobin promoter.

J Dennig1, G Hagen, M Beato, G Suske.   

Abstract

Previous analyses of the uteroglobin promoter revealed seven distinct regions, which contribute to its overall activity in epithelial cells from endometrium and lung. Most significantly, a mutation of the promoter sequence around 65 base pairs upstream of the transcriptional start site severely impairs promoter activity. The transcription factor acting through this sequence has not been identified yet. Here, we report that members of the Sp transcription factor family specifically recognize this non-classical GC box, in addition to another functional motif located 230 base pairs upstream of the transcriptional start site. We have characterized in detail the interaction of recombinant Sp3 with both motifs by DNase I footprinting and methylation protection using the wild-type uteroglobin promoter and various linker scanning mutants as templates. Electrophoretic mobility shift analyses show that Sp1 and Sp3 both bind with similar affinity to these elements. We demonstrate that the DNA-binding proteins in the endometrial cell line Ishikawa which recognize these motifs are also Sp1 and Sp3. Gene transfer experiments into Drosophila Schneider cells that do not contain endogenous Sp factors revealed that both DNA motifs respond to transiently expressed Sp1 and Sp3. Our results show thus that the level of transcription from the uteroglobin promoter is controlled by members of the Sp transcription factor family through unusual Sp binding sites.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7759528     DOI: 10.1074/jbc.270.21.12737

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Differential regulation of the human nidogen gene promoter region by a novel cell-type-specific silencer element.

Authors:  M Zedlacher; M Schmoll; K Zimmermann; O Horstkorte; R Nischt
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

2.  Transcription factor Sp3 is regulated by acetylation.

Authors:  H Braun; R Koop; A Ertmer; S Nacht; G Suske
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

3.  Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription.

Authors:  S B Kennett; A J Udvadia; J M Horowitz
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

4.  Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1.

Authors:  S Srivastava; M N Weitzmann; R B Kimble; M Rizzo; M Zahner; J Milbrandt; F P Ross; R Pacifici
Journal:  J Clin Invest       Date:  1998-11-15       Impact factor: 14.808

5.  Characterization of the TATA-less core promoter of the cell cycle-regulated cdc25C gene.

Authors:  K Körner; L A Wolfraim; F C Lucibello; R Müller
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

6.  Overlapping Sp1 and AP2 binding sites in a promoter element of the lens-specific MIP gene.

Authors:  C Ohtaka-Maruyama; X Wang; H Ge; A B Chepelinsky
Journal:  Nucleic Acids Res       Date:  1998-01-15       Impact factor: 16.971

7.  Sp3 is a transcriptional activator of the human alpha2(I) collagen gene.

Authors:  H Ihn; M Trojanowska
Journal:  Nucleic Acids Res       Date:  1997-09-15       Impact factor: 16.971

8.  Binding of YY1 to a site overlapping a weak TATA box is essential for transcription from the uteroglobin promoter in endometrial cells.

Authors:  J Klug; M Beato
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

9.  Oct-1 interacts with conserved motifs in the human thyroid transcription factor 1 gene minimal promoter.

Authors:  C D Bingle; S Gowan
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

10.  The CD14 C-159T polymorphism is not associated with asthma or asthma severity in an Australian adult population.

Authors:  M-A Kedda; F Lose; D Duffy; E Bell; P J Thompson; J Upham
Journal:  Thorax       Date:  2005-03       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.